A detailed history of Bank Of America Corp transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,251,323 shares of RLAY stock, worth $5.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,251,323
Previous 795,482 57.3%
Holding current value
$5.94 Million
Previous $5.19 Million 70.83%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.23 - $9.51 $2.84 Million - $4.34 Million
455,841 Added 57.3%
1,251,323 $8.86 Million
Q2 2024

Aug 14, 2024

BUY
$5.9 - $8.02 $317,296 - $431,307
53,779 Added 7.25%
795,482 $5.19 Million
Q1 2024

May 15, 2024

BUY
$7.5 - $12.07 $3.22 Million - $5.18 Million
429,513 Added 137.58%
741,703 $6.16 Million
Q4 2023

Feb 14, 2024

SELL
$6.01 - $11.48 $400,061 - $764,177
-66,566 Reduced 17.57%
312,190 $3.44 Million
Q2 2023

Aug 14, 2023

SELL
$9.99 - $18.27 $2.47 Million - $4.52 Million
-247,147 Reduced 39.49%
378,756 $4.76 Million
Q1 2023

May 12, 2023

BUY
$15.0 - $22.76 $4.07 Million - $6.18 Million
271,414 Added 76.56%
625,903 $10.3 Million
Q4 2022

Feb 10, 2023

BUY
$14.16 - $24.02 $2.87 Million - $4.86 Million
202,463 Added 133.18%
354,489 $5.3 Million
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $554,116 - $961,961
30,665 Added 25.27%
152,026 $3.4 Million
Q2 2022

Aug 12, 2022

BUY
$13.31 - $34.88 $486,374 - $1.27 Million
36,542 Added 43.08%
121,361 $2.03 Million
Q1 2022

May 16, 2022

SELL
$20.26 - $32.36 $1.38 Million - $2.21 Million
-68,325 Reduced 44.61%
84,819 $2.54 Million
Q4 2021

Feb 08, 2022

BUY
$26.0 - $37.03 $3.04 Million - $4.33 Million
116,834 Added 321.77%
153,144 $4.7 Million
Q3 2021

Nov 15, 2021

SELL
$29.75 - $37.99 $743,333 - $949,218
-24,986 Reduced 40.76%
36,310 $1.15 Million
Q2 2021

Sep 13, 2021

BUY
$27.5 - $38.19 $1.69 Million - $2.34 Million
61,296 New
61,296 $2.24 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $571M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.